Expert perspectives on
burden of glaucoma and
the BIM-IOL System

Watch experts discuss the changing landscape of glaucoma treatment for all cataract surgeons

Hear how emerging longer-term data may inform the future of sustained drug delivery.

FPO

Rethinking Glaucoma Management in Comprehensive Ophthalmology

Darrell White, MD

FPO

Seamless Integration of Sustained Drug Delivery Into Cataract Surgery

Jai G. Parekh, MD, MBA, FAAO

FPO

What Sustained Drug Delivery Could Mean for Glaucoma Care

Preeya Gupta, MD

FPO

Consistent Drug Delivery Without the
Burden of Drops

Sam Garg, MD

Hear from a leading Phase 1/2 study investigator on 3-month data

Dr. Jeffrey A. Kammer shares key insights from early clinical evaluation.

FPO

Phase 1/2 Results: Safety & Efficacy Overview

Jeffrey A. Kammer, MD

FPO

Seamless Integration Into Cataract Surgery

Jeffrey A. Kammer, MD

FPO

What Sustained Delivery Means for Patients

Jeffrey A. Kammer, MD

Explore the future of our sustained drug delivery platform.